., and bones, and it�s not clear how the drugs will affect them after long-term use.
.

.
fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and
.
.
"this should not have happened and should never be allowed to happen again to another vulnerable person or their family.
.